@article{d4220eef059e4244bc506e492c973f23,
title = "Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer",
keywords = "Breast cancer, combination therapies, cyclophosphamide, GM-CSF, oncolytic adenovirus, oncolytic virotherapy, triple-negative breast cancer, CHEMOTHERAPY-REFRACTORY CANCER, DOSE METRONOMIC CHEMOTHERAPY, COLONY-STIMULATING FACTOR, OVARIAN-CANCER, SOLID TUMORS, REPLICATING ADENOVIRUS, THERAPEUTIC-EFFICACY, RESPONSE EVALUATION, ANTITUMOR-ACTIVITY, 3122 Cancers",
author = "Simona Bramante and Anniina Koski and Ilkka Liikanen and Lotta Vassilev and Minna Oksanen and Mikko Siurala and Raita Heiskanen and Tiina Hakonen and Timo Joensuu and Anna Kanerva and Sari Pesonen and Akseli Hemminki",
year = "2016",
doi = "10.1080/2162402X.2015.1078057",
language = "English",
volume = "5",
journal = "OncoImmunology",
issn = "2162-402X",
publisher = "Taylor and Francis Ltd.",
number = "2",
}